Wu Yan, Ghaly Evone S
School of Pharmacy, University of Puerto Rico, San Juan.
P R Health Sci J. 2006 Mar;25(1):75-83.
The main objective of this research is to investigate the principles underlying the dissolution process, study the phenomena of drug release in laminar flow, and better understand the effect of hydrodynamic condition on drug dissolution, in order to predict drug dissolution from a solid dosage form. Two drug models were selected, theophylline (Class I) and naproxen (Class II), and were formulated into conventional tablets containing 105 mg theophylline or 300 mg naproxen using wet granulation method. Additionally theophylline (105 mg) and naproxen (300 mg) matrices containing 30% hydroxypropylmethylcellulose (HPMC) polymer were prepared by direct compression and tested for dissolution using both USP II and IV dissolution apparatus. Tablets were tested for dissolution (USP IV) using different cell diameter, flow rate, and different position of the tablet inside the cell. In general, the drug dissolution at a given time is a direct function of the flow rate, increasing the flow rate increases drug release. The use of a small cell resulted in faster drug dissolution and higher Reynold's Number than using a large cell. Tablet position in the cell, also has an effect on drug dissolution, inserting the tablet in a horizontal position inside the cell gave faster dissolution than a vertical position. The hydrodynamic conditions did not affect the drug dissolution from HPMC controlled release tablets indicating that the drug dissolution is controlled by the matrix. An equation to predict drug dissolution from conventional tablets was established: Sh=-21.36+10.58Re(1/2) where R2=0.98. This study demonstrated that hydrodynamic conditions, and type of dissolution testing apparatus used have an effect on dissolution rate, mass transfer rate, and film thickness underlying dissolution process.
本研究的主要目的是探究溶解过程的基本原理,研究层流中药物释放现象,更好地理解流体动力学条件对药物溶解的影响,以便预测固体剂型的药物溶解情况。选择了两种药物模型,即茶碱(I类)和萘普生(II类),并采用湿法制粒工艺将其制成含有105mg茶碱或300mg萘普生的常规片剂。此外,通过直接压片制备了含有30%羟丙基甲基纤维素(HPMC)聚合物的茶碱(105mg)和萘普生(300mg)基质,并使用美国药典II型和IV型溶出度测定仪进行溶出度测试。使用不同的池直径、流速以及片剂在池内的不同位置对片剂进行溶出度测试(美国药典IV型)。一般来说,给定时间的药物溶解是流速的直接函数,流速增加会使药物释放增加。与使用大池相比,使用小池会使药物溶解更快且雷诺数更高。片剂在池中的位置也会对药物溶解产生影响,将片剂水平插入池内比垂直插入时溶出更快。流体动力学条件对HPMC控释片剂的药物溶解没有影响,这表明药物溶解受基质控制。建立了一个预测常规片剂药物溶解的方程:Sh = -21.36 + 10.58Re(1/2),其中R2 = 0.98。本研究表明,流体动力学条件以及所使用的溶出度测试仪器类型对溶解速率、传质速率以及溶解过程中的膜厚度有影响。